Written by Klarity Editorial Team
Published: Aug 25, 2026

Last updated: August 25, 2026
Pipamperone is a typical butyrophenone antipsychotic sold in several European countries as Dipiperon (also Dipiperal, Piperonil, Piperonyl, and Propitan). Janssen developed it in 1961. U.S. retail pharmacies do not stock it as a current option. Families type the name after a Belgian or German bottle, an old discharge list, or a paper from a hospital stay abroad. This guide explains what pipamperone is, how labels describe dose ranges, and how telehealth can still help someone who needs an evaluation for psychosis, agitation, sleep disruption, or related symptoms.
This page is educational. It is not a diagnosis, a refill promise, or a claim that any plan will pay for a specific drug. Coverage varies by plan. Verify benefits before you book.
See conditions Klarity clinicians evaluate or learn how online anxiety and related mental health visits work.
Pipamperone is the international name. Dipiperon is the brand most families remember from Belgium, Germany, and nearby markets. PubChem lists CID 4830. DrugBank accession is DB09286. The ATC code is N05AD05, in the same butyrophenone group as haloperidol, though the clinical personality is quieter and more sedating at typical European doses.
DrugBank’s public card is short and specific: a typical antipsychotic of the butyrophenone family used in the treatment of schizophrenia, developed by Janssen Pharmaceutica in 1961. Wikipedia adds that it has also been used as a sleep aid in depression and lists brand names Dipiperon, Dipiperal, Piperonil, Piperonyl, and Propitan. U.S. Adopted Name (USAN) exists; that does not mean a current FDA-marketed product sits on U.S. shelves.
If you found “Dipiperon 40 mg” on a European blister, you are looking at pipamperone. If you only searched “floropipamide” or “R-3345,” you are still looking at the same molecule.
No commercial U.S. product is on pharmacy shelves as a routine fill. Clinical trials started in the United States in 1963, according to secondary histories, but the drug’s commercial life stayed largely in Europe. A U.S. clinician cannot transfer a Belgian Dipiperon script to a neighborhood pharmacy the way they can transfer many FDA-available antipsychotics.
People search “pipamperone” and “Dipiperon” after a move from Europe, after a family member’s old bottle, or after reading a paper that mentions low-dose 5-HT2A blockade. The U.S. answer is substitution with an FDA-available oral or long-acting antipsychotic, not a Dipiperon transfer. Do not import unlabeled tablets. A clinician licensed in your state should redesign the plan.
Browse condition pages if you need a starting point for what a visit can cover.
Pipamperone acts as an antagonist at 5-HT2A, 5-HT2B, 5-HT2C, D2, D3, D4, and alpha-1/alpha-2 adrenergic receptors. Binding tables often show much higher affinity for 5-HT2A and D4 than for D2 (on the order of 15-fold for D4 versus D2). Histamine H1 and muscarinic affinity are low. That receptor mix is why some authors treat it as a historical bridge to later “atypical” drugs, even though catalogs still list it as a first-generation butyrophenone.
Those binding numbers come from laboratory tables. They do not tell you which U.S. medicine is the right substitute. Haloperidol is a closer chemical cousin and a much more activating, high-potency option. Quetiapine or other sedating second-generation agents sometimes appear in conversations about sleep and agitation, but that is a clinical judgment, not a one-to-one swap.
These figures are from secondary summaries of conventional European labeling. They are not a U.S. prescribing guide.
EP2236138A1, a patent on low-dose pipamperone for mood and anxiety research, recites the conventional adult start as 40 to 80 mg a day, with a stated maximum of 360 mg a day. Forty-milligram tablets are the pack strength most often photographed in Germany. Half-life listings of 17-22 hours support once- or twice-daily schedules on those labels.
Treat those numbers as product history. A U.S. clinician cannot fill Dipiperon at a standard U.S. retail pharmacy. Do not copy a European dose onto leftover tablets or an overseas order.
Butyrophenones as a class carry the same family warnings you already know from haloperidol: extrapyramidal symptoms, tardive dyskinesia with long use, neuroleptic malignant syndrome (rare), QT prolongation risk, and a higher death rate when antipsychotics are used in older adults with dementia-related psychosis. Pipamperone appears on QT-prolonging drug lists. Do not combine leftover tablets with other QT-prolonging medicines without a clinician who can see an ECG and a full list.
Do not import research chemical. Do not crush old European tablets to “match” a U.S. medicine. If someone is suicidal, violent, or unable to care for themselves, that is an emergency: call 988 or go to an emergency department.
A video visit cannot put Dipiperon on a U.S. shelf. It can still:
HHS states that Medicare patients can permanently receive behavioral/mental telehealth in the home, with no geographic originating-site restriction, and that several other Medicare telehealth flexibilities run through December 31, 2027. The policy page was last updated February 5, 2026. Commercial and Medicaid rules differ. Coverage varies by plan. Verify benefits before you book.
Klarity’s network includes 2,000+ licensed providers. A visit is an evaluation, not a promise of a named drug. If worry, restlessness, or tension is the main problem you want to discuss, start with online anxiety treatment. If you are mapping symptoms more broadly, use the conditions index.
Insurance may help pay for the visit. It typically does not create a special exception for an unapproved import. Ask your plan what it covers. If you are in crisis, call or text 988.
Yes. Dipiperon is the best-known brand. Dipiperal, Piperonil, Piperonyl, and Propitan point to the same active ingredient.
They cannot fill a medicine U.S. pharmacies do not stock. They can evaluate symptoms and discuss FDA-available alternatives.
Catalogs list it as a typical butyrophenone. Receptor tables show stronger 5-HT2A and D4 blockade than D2 at low dose, which is why some papers call it a forerunner of later atypicals.
Do not self-taper from an old bottle without medical advice. Bring the name, strength, and dates to a licensed clinician. Dispose of unused medicine through a take-back program when you can.
See if an online mental health visit is a fit or review conditions Klarity evaluates. Coverage varies by plan. Verify benefits before you book.
Find the right provider for your needs — select your state to find expert care near you.